Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 5
1966 2
1967 2
1968 4
1969 7
1970 8
1971 5
1972 6
1973 13
1974 9
1975 7
1976 16
1977 6
1978 13
1979 13
1980 14
1981 14
1982 13
1983 16
1984 19
1985 27
1986 19
1987 31
1988 33
1989 41
1990 43
1991 46
1992 52
1993 61
1994 50
1995 58
1996 52
1997 68
1998 80
1999 68
2000 82
2001 93
2002 81
2003 117
2004 94
2005 88
2006 106
2007 117
2008 99
2009 96
2010 104
2011 103
2012 101
2013 135
2014 114
2015 114
2016 113
2017 105
2018 91
2019 83
2020 107
2021 130
2022 110
2023 90
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

3,202 results

Results by year

Filters applied: . Clear all
Page 1
Fibrinolysis and the control of blood coagulation.
Chapin JC, Hajjar KA. Chapin JC, et al. Blood Rev. 2015 Jan;29(1):17-24. doi: 10.1016/j.blre.2014.09.003. Epub 2014 Sep 16. Blood Rev. 2015. PMID: 25294122 Free PMC article. Review.
Regulation of the fibrinolytic system, like that of the coagulation cascade, is accomplished by a wide array of cofactors, receptors, and inhibitors. ...Here, we summarize the basic elements of the fibrinolytic system, points of interaction with the coagulation path …
Regulation of the fibrinolytic system, like that of the coagulation cascade, is accomplished by a wide array of cofactors, receptors, …
The D-dimer assay.
Johnson ED, Schell JC, Rodgers GM. Johnson ED, et al. Am J Hematol. 2019 Jul;94(7):833-839. doi: 10.1002/ajh.25482. Epub 2019 Apr 19. Am J Hematol. 2019. PMID: 30945756 Free article. Review.
Because of this, the D-dimer serves as a valuable marker of activation of coagulation and fibrinolysis in a number of clinical scenarios. Most commonly, D-dimer has been extensively investigated for excluding the diagnosis of venous thromboembolism (VTE) and is used routin …
Because of this, the D-dimer serves as a valuable marker of activation of coagulation and fibrinolysis in a number of clinical scenar …
Disorders of Fibrinogen and Fibrinolysis.
May JE, Wolberg AS, Lim MY. May JE, et al. Hematol Oncol Clin North Am. 2021 Dec;35(6):1197-1217. doi: 10.1016/j.hoc.2021.07.011. Epub 2021 Aug 14. Hematol Oncol Clin North Am. 2021. PMID: 34404562 Free PMC article. Review.
Fibrinogen plays a fundamental role in coagulation through its support for platelet aggregation and its conversion to fibrin. ...This review summarizes (i) the basic elements of fibrin(ogen) and its role in coagulation and the fibrinolytic system; (ii) the laborator …
Fibrinogen plays a fundamental role in coagulation through its support for platelet aggregation and its conversion to fibrin. ...This …
AGA Clinical Practice Update: Coagulation in Cirrhosis.
O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. O'Leary JG, et al. Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12. Gastroenterology. 2019. PMID: 30986390 Review.
The intent is to evaluate the current data on mechanism of altered coagulation in patients with cirrhosis, provide guidance on the use of currently available testing of the coagulation cascade, and help practitioners use anticoagulation and pro-coagulants app …
The intent is to evaluate the current data on mechanism of altered coagulation in patients with cirrhosis, provide guidance on the us …
Haemostatic alterations and management of haemostasis in patients with cirrhosis.
Lisman T, Caldwell SH, Intagliata NM. Lisman T, et al. J Hepatol. 2022 Jun;76(6):1291-1305. doi: 10.1016/j.jhep.2021.11.004. J Hepatol. 2022. PMID: 35589251 Free article. Review.
Conversely, clinicians have become more aware of the need for anti-thrombotic therapy, even in those patients with abnormal routine coagulation tests. This paper will outline recent advances in pathogenesis, prevention and treatment of both bleeding and throm …
Conversely, clinicians have become more aware of the need for anti-thrombotic therapy, even in those patients with abnormal routine …
Coagulation Testing in the Core Laboratory.
Winter WE, Flax SD, Harris NS. Winter WE, et al. Lab Med. 2017 Nov 8;48(4):295-313. doi: 10.1093/labmed/lmx050. Lab Med. 2017. PMID: 29126301 Review.
The role of vitamin K is to assist in the addition of gamma carboxylate groups to glutamic acids in the "GLA" domains of these factors.In vitro the intrinsic pathway is initiated when fresh whole blood is placed in a glass tube. The negative charge of the glass initiates t …
The role of vitamin K is to assist in the addition of gamma carboxylate groups to glutamic acids in the "GLA" domains of these factors.In vi …
COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H, Ogawa H. Asakura H, et al. Int J Hematol. 2021 Jan;113(1):45-57. doi: 10.1007/s12185-020-03029-y. Epub 2020 Nov 7. Int J Hematol. 2021. PMID: 33161508 Free PMC article. Review.
The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The most frequently reported coagulation/fibrinolytic abnormality in COVID-19 is the i …
The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression of thrombosis, and disseminated intravascular coag …
Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests.
Favaloro EJ. Favaloro EJ. Am J Hematol. 2020 Jan;95(1):117-128. doi: 10.1002/ajh.25669. Epub 2019 Nov 20. Am J Hematol. 2020. PMID: 31674066 Free article. Review.
Coagulation testing underpins the investigation of hemostasis and/or monitoring of anticoagulation therapy for prevention and/or treatment of thrombosis related pathology. Assessment of coagulation results requires comparison against a normal reference range or inte …
Coagulation testing underpins the investigation of hemostasis and/or monitoring of anticoagulation therapy for prevention and/or trea …
Current and future therapies for haemophilia-Beyond factor replacement therapies.
Nogami K, Shima M. Nogami K, et al. Br J Haematol. 2023 Jan;200(1):23-34. doi: 10.1111/bjh.18379. Epub 2022 Jul 23. Br J Haematol. 2023. PMID: 35869698 Review.
Some non-factor products that work by facilitating the coagulation pathway (emicizumab) and blocking the anticoagulant pathway (fitusiran, concizumab and marstacimab) for patients with haemophilia (H) have been developed, and clinical trials using these products are curren …
Some non-factor products that work by facilitating the coagulation pathway (emicizumab) and blocking the anticoagulant pathway (fitus …
Coagulation.
Chee YL. Chee YL. J R Coll Physicians Edinb. 2014;44(1):42-5. doi: 10.4997/JRCPE.2014.110. J R Coll Physicians Edinb. 2014. PMID: 24995447 Review.
The prothrombin time (PT) and activated partial thromboplastin time (APTT) only test the coagulation protein compartment of the system and results have to be carefully interpreted in the context of the clinical presentation and assay limitations. ...Of these indications, r …
The prothrombin time (PT) and activated partial thromboplastin time (APTT) only test the coagulation protein compartment of the syste …
3,202 results